U.S. Markets closed

Illumina's board confirms unanimous rejection of Roche’s revised offer

Illumina (ILMN) announced that its Board of Directors has unanimously rejected Roche’s (RHHBY) revised offer to acquire Illumina for $51.00 per share in cash. Illumina urges its stockholders not to tender any shares and to vote in support of Illumina’s directors and against Roche’s additional proposals.